{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:17:54Z","timestamp":1792653474921,"version":"4.5.0"},"reference-count":193,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Clinical Laboratory Sciences"],"published-print":{"date-parts":[[2023,7,4]]},"DOI":"10.1080\/10408363.2023.2179968","type":"journal-article","created":{"date-parts":[[2023,3,6]],"date-time":"2023-03-06T12:01:27Z","timestamp":1678104087000},"page":"366-381","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Inherited causes of exocrine pancreatic insufficiency in pediatric patients: clinical presentation and laboratory testing"],"prefix":"10.1080","volume":"60","author":[{"given":"Tatiana N.","family":"Yuzyuk","sequence":"first","affiliation":[{"name":"Department of Pathology, University of Utah\/ARUP Laboratories, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Utah\/ARUP Laboratories, Salt Lake City, UT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Laboratories, Seattle Children\u2019s Hospital, Seattle, WA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,3,6]]},"reference":[{"key":"e_1_3_1_2_1","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Pancreatitis in Children 2020. Available from: https:\/\/www.niddk.nih.gov\/news\/archive\/2020\/story-discovery-prancreatitis-children."},{"key":"e_1_3_1_3_1","unstructured":"Cystic Fibrosis Foundation Bethesda MD www.cff.org. (accessed Sept 20 2022. Bethesda MD."},{"issue":"3","key":"e_1_3_1_4_1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo J","year":"2022","unstructured":"Guo J, Garratt A, Hill A. Worldwide rates of diagnosis and effective treatment for cystic fibrosis. J Cyst Fibros. 2022 ;21(3):456\u2013462.","journal-title":"J Cyst Fibros"},{"issue":"10290","key":"e_1_3_1_5_1","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg M","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, et\u00a0al. Cystic fibrosis. Lancet. 2021;397(10290):2195\u20132211.","journal-title":"Lancet"},{"issue":"1","key":"e_1_3_1_6_1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/cells11010054","article-title":"Bicarbonate transport in cystic fibrosis and pancreatitis","volume":"11","author":"Angyal D","year":"2021","unstructured":"Angyal D, Bijvelds MJC, Bruno MJ, et\u00a0al. Bicarbonate transport in cystic fibrosis and pancreatitis. Cells. 2021;11(1):54.","journal-title":"Cells"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fendo.2018.00020","article-title":"Cystic fibrosis-related diabetes","volume":"9","author":"Kayani K","year":"2018","unstructured":"Kayani K, Mohammed R, Mohiaddin H. Cystic fibrosis-related diabetes. Front Endocrinol . 2018;9:20.","journal-title":"Front Endocrinol"},{"issue":"22","key":"e_1_3_1_8_1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM199011293232203","article-title":"The relation between genotype and phenotype in cystic fibrosis\u2013analysis of the most common mutation (Delta F508)","volume":"323","author":"Kerem E","year":"1990","unstructured":"Kerem E, Corey M, Kerem BS, et\u00a0al. The relation between genotype and phenotype in cystic fibrosis\u2013analysis of the most common mutation (Delta F508). N Engl J Med. 1990; 323(22):1517\u20131522.","journal-title":"N Engl J Med"},{"issue":"16","key":"e_1_3_1_9_1","first-page":"2","article-title":"Pathophysiology of the exocrine pancreas in cystic fibrosis","volume":"82","author":"Durie PR","year":"1989","unstructured":"Durie PR, Forstner GG. Pathophysiology of the exocrine pancreas in cystic fibrosis. J R Soc Med. 1989;82(Suppl 16):2\u201310.","journal-title":"J R Soc Med"},{"issue":"4","key":"e_1_3_1_10_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2012.10.008","article-title":"Evolution of pancreatic function during the first year in infants with cystic fibrosis","volume":"162","author":"O'Sullivan BP","year":"2013","unstructured":"O'Sullivan BP, Baker D, Leung KG, et\u00a0al. Evolution of pancreatic function during the first year in infants with cystic fibrosis. J Pediatr. 2013;162(4):808\u2013812.e1.","journal-title":"J Pediatr"},{"issue":"4","key":"e_1_3_1_11_1","doi-asserted-by":"crossref","first-page":"e463-9","DOI":"10.1542\/peds.2004-1764","article-title":"Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype","volume":"115","author":"De Boeck K","year":"2005","unstructured":"De Boeck K, Weren M, Proesmans M, et\u00a0al. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype. Pediatrics. 2005; 115(4):e463-9\u2013e469.","journal-title":"Pediatrics"},{"issue":"6","key":"e_1_3_1_12_1","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1053\/gast.2002.37042","article-title":"Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis","volume":"123","author":"Durno C","year":"2002","unstructured":"Durno C, Corey M, Zielenski J, et\u00a0al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology. 2002; 123(6):1857\u20131864.","journal-title":"Gastroenterology"},{"issue":"1","key":"e_1_3_1_13_1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.gastro.2010.09.046","article-title":"Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis","volume":"140","author":"Ooi CY","year":"2011","unstructured":"Ooi CY, Dorfman R, Cipolli M, et\u00a0al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011; 140(1):153\u2013161.","journal-title":"Gastroenterology"},{"issue":"6","key":"e_1_3_1_14_1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/MPA.0000000000001053","article-title":"Recurrent acute pancreatitis: international state-of-the-science conference with recommendations","volume":"47","author":"Guda NM","year":"2018","unstructured":"Guda NM, Muddana V, Whitcomb DC, et\u00a0al. Recurrent acute pancreatitis: international state-of-the-science conference with recommendations. Pancreas. 2018; 47(6):653\u2013666.","journal-title":"Pancreas"},{"issue":"2","key":"e_1_3_1_15_1","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.jcf.2017.07.004","article-title":"Pancreatitis and pancreatic cystosis in cystic fibrosis","volume":"16","author":"Freeman AJ","year":"2017","unstructured":"Freeman AJ, Ooi CY. Pancreatitis and pancreatic cystosis in cystic fibrosis. J Cyst Fibros. 2017;16 Suppl 2(Suppl 2):S79\u2013S86.","journal-title":"J Cyst Fibros"},{"issue":"5","key":"e_1_3_1_16_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MOP.0000000000000934","article-title":"Pancreatic complications in children with cystic fibrosis","volume":"32","author":"Sellers ZM.","year":"2020","unstructured":"Sellers ZM. Pancreatic complications in children with cystic fibrosis. Curr Opin Pediatr. 2020;32(5):661\u2013667.","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"e_1_3_1_17_1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.3390\/nu14071341","article-title":"Pancreatic enzyme replacement therapy in cystic fibrosis","volume":"14","author":"Freswick PN","year":"2022","unstructured":"Freswick PN, Reid EK, Mascarenhas MR. Pancreatic enzyme replacement therapy in cystic fibrosis. Nutrients. 2022;14(7):1341.","journal-title":"Nutrients"},{"issue":"2","key":"e_1_3_1_18_1","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1016\/j.jcf.2017.06.011","article-title":"Pancreatic insufficiency in cystic fibrosis","volume":"16","author":"Singh VK","year":"2017","unstructured":"Singh VK, Schwarzenberg SJ. Pancreatic insufficiency in cystic fibrosis. J Cyst Fibros. 2017;16(Suppl 2):S70\u2013S78.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"e_1_3_1_19_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe \u2013 Where is it worthwhile?","volume":"6","author":"Scotet V","year":"2020","unstructured":"Scotet V, Gutierrez H, Farrell PM. Newborn screening for CF across the globe \u2013 Where is it worthwhile? Int J Neonatal Screen. 2020; 6(1):18.","journal-title":"Int J Neonatal Screen"},{"issue":"6","key":"e_1_3_1_20_1","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1542\/peds.113.6.1573","article-title":"Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections","volume":"113","author":"Comeau AM","year":"2004","unstructured":"Comeau AM, Parad RB, Dorkin HL, et\u00a0al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004; 113(6):1573\u20131581.","journal-title":"Pediatrics"},{"issue":"1","key":"e_1_3_1_21_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/gim.2016.48","article-title":"Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients","volume":"19","author":"Pique L","year":"2017","unstructured":"Pique L, Graham S, Pearl M, et\u00a0al. Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients. Genet Med. 2017;19(1):36\u201344.","journal-title":"Genet Med"},{"issue":"1","key":"e_1_3_1_22_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: a global perspective","volume":"8","author":"Bell SC","year":"2020","unstructured":"Bell SC, Mall MA, Gutierrez H, et\u00a0al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020; 8(1):65\u2013124.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"e_1_3_1_23_1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0039-1696726","article-title":"Growth and nutrition in cystic fibrosis","volume":"40","author":"Brownell JN","year":"2019","unstructured":"Brownell JN, Bashaw H, Stallings VA. Growth and nutrition in cystic fibrosis. Semin Respir Crit Care Med. 2019;40(6):775\u2013791.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"e_1_3_1_24_1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00005176-199708000-00001","article-title":"Malnutrition in children with cystic fibrosis: the energy-balance equation","volume":"25","author":"Reilly JJ","year":"1997","unstructured":"Reilly JJ, Edwards CA, Weaver LT. Malnutrition in children with cystic fibrosis: the energy-balance equation. J Pediatr Gastroenterol Nutr. 1997;25(2):127\u2013136.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"e_1_3_1_25_1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.3945\/ajcn.112.051409","article-title":"Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study","volume":"97","author":"Stephenson AL","year":"2013","unstructured":"Stephenson AL, Mannik LA, Walsh S, et\u00a0al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am J Clin Nutr. 2013; 97(4):872\u2013877.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"e_1_3_1_26_1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jpeds.2012.08.040","article-title":"Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis","volume":"162","author":"Yen EH","year":"2013","unstructured":"Yen EH, Quinton H, Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J Pediatr. 2013;162(3):530\u2013535 e1.","journal-title":"J Pediatr"},{"issue":"2","key":"e_1_3_1_27_1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcf.2006.01.005","article-title":"Fecal elastase-1: utility in pancreatic function in cystic fibrosis","volume":"5","author":"Daftary A","year":"2006","unstructured":"Daftary A, Acton J, Heubi J, et\u00a0al. Fecal elastase-1: utility in pancreatic function in cystic fibrosis. J Cyst Fibros. 2006;5(2):71\u201376.","journal-title":"J Cyst Fibros"},{"issue":"1","key":"e_1_3_1_28_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-017-0783-y","article-title":"Practical guide to exocrine pancreatic insufficiency - Breaking the myths","volume":"15","author":"Struyvenberg MR","year":"2017","unstructured":"Struyvenberg MR, Martin CR, Freedman SD. Practical guide to exocrine pancreatic insufficiency - Breaking the myths. BMC Med. 2017; 15(1):29.","journal-title":"BMC Med"},{"issue":"9","key":"e_1_3_1_29_1","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00431-021-04168-y","article-title":"A new era for people with cystic fibrosis","volume":"180","author":"Bierlaagh MC","year":"2021","unstructured":"Bierlaagh MC, Muilwijk D, Beekman JM, et\u00a0al. A new era for people with cystic fibrosis. Eur J Pediatr. 2021; 180(9):2731\u20132739.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"e_1_3_1_30_1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcf.2021.03.018","article-title":"Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy","volume":"20","author":"Fortner CN","year":"2021","unstructured":"Fortner CN, Seguin JM, Kay DM. Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy. J Cyst Fibros. 2021; 20(5):835\u2013836.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"e_1_3_1_31_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S2213-2600(15)00545-7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2\u20135 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study","volume":"4","author":"Davies JC","year":"2016","unstructured":"Davies JC, Cunningham S, Harris WT, et\u00a0al. Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2\u20135 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. Lancet Respir Med. 2016;4(2):107\u2013115.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"e_1_3_1_32_1","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jcf.2019.03.009","article-title":"An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2\u20135years (KLIMB)","volume":"18","author":"Rosenfeld M","year":"2019","unstructured":"Rosenfeld M, Cunningham S, Harris WT, et\u00a0al. An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2\u20135years (KLIMB). J Cyst Fibros. 2019;18(6):838\u2013843.","journal-title":"J Cyst Fibros"},{"issue":"7","key":"e_1_3_1_33_1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-2600(18)30202-9","article-title":"Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study","volume":"6","author":"Rosenfeld M","year":"2018","unstructured":"Rosenfeld M, Wainwright CE, Higgins M, et\u00a0al. Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL): a phase 3 single-arm study. Lancet Respir Med. 2018; 6(7):545\u2013553.","journal-title":"Lancet Respir Med"},{"key":"e_1_3_1_34_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations","volume":"201","author":"Stallings VA","year":"2018","unstructured":"Stallings VA, Sainath N, Oberle M, et\u00a0al. Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations. J Pediatr. 2018;201:229\u2013237.e4.","journal-title":"J Pediatr"},{"issue":"8","key":"e_1_3_1_35_1","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1002\/ppul.24353","article-title":"Time for a gut check: pancreatic sufficiency resulting from CFTR modulator use","volume":"54","author":"Megalaa R","year":"2019","unstructured":"Megalaa R, Gopalareddy V, Champion E, et\u00a0al. Time for a gut check: pancreatic sufficiency resulting from CFTR modulator use. Pediatr Pulmonol. 2019;54(8):E16\u2013e18.","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"e_1_3_1_36_1","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/ppul.24952","article-title":"Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor","volume":"55","author":"Smith H","year":"2020","unstructured":"Smith H, Rayment JH. Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor. Pediatr Pulmonol. 2020; 55(10):2493\u20132494. `","journal-title":"Pediatr Pulmonol"},{"issue":"12","key":"e_1_3_1_37_1","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/ppul.25065","article-title":"Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor","volume":"55","author":"Munce D","year":"2020","unstructured":"Munce D, Lim M, Akong K. Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor. Pediatr Pulmonol. 2020; 55(12):3381\u20133383.","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"e_1_3_1_38_1","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.pan.2019.09.014","article-title":"Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis","volume":"19","author":"Akshintala VS","year":"2019","unstructured":"Akshintala VS, Kamal A, Faghih M, et\u00a0al. Cystic fibrosis transmembrane conductance regulator modulators reduce the risk of recurrent acute pancreatitis among adult patients with pancreas sufficient cystic fibrosis. Pancreatology. 2019; 19(8):1023\u20131026.","journal-title":"Pancreatology"},{"issue":"12","key":"e_1_3_1_39_1","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.14309\/ajg.0000000000001527","article-title":"Cystic fibrosis transmembrane conductance regulator modulator use is associated with reduced pancreatitis hospitalizations in patients with cystic fibrosis","volume":"116","author":"Ramsey ML","year":"2021","unstructured":"Ramsey ML, Gokun Y, Sobotka LA, et\u00a0al. Cystic fibrosis transmembrane conductance regulator modulator use is associated with reduced pancreatitis hospitalizations in patients with cystic fibrosis. Am J Gastroenterol. 2021;116(12):2446\u20132454.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"e_1_3_1_40_1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jcf.2021.09.010","article-title":"CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis","volume":"21","author":"Gould MJ","year":"2022","unstructured":"Gould MJ, Smith H, Rayment JH, et\u00a0al. CFTR modulators increase risk of acute pancreatitis in pancreatic insufficient patients with cystic fibrosis. J Cyst Fibros. 2022; 21(4):600\u2013602.","journal-title":"J Cyst Fibros"},{"key":"e_1_3_1_41_1","doi-asserted-by":"crossref","first-page":"914790","DOI":"10.3389\/fped.2022.914790","article-title":"The exocrine pancreas in cystic fibrosis in the era of CFTR modulation: a mini review","volume":"10","author":"McKay IR","year":"2022","unstructured":"McKay IR, Ooi CY. The exocrine pancreas in cystic fibrosis in the era of CFTR modulation: a mini review. Front Pediatr. 2022;10:914790.","journal-title":"Front Pediatr"},{"issue":"2","key":"e_1_3_1_42_1","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MPG.0000000000002405","article-title":"Risk factors for rapid progression from acute recurrent to chronic pancreatitis in children: report from INSPPIRE","volume":"69","author":"Liu QY","year":"2019","unstructured":"Liu QY, Abu-El-Haija M, Husain SZ, et\u00a0al. Risk factors for rapid progression from acute recurrent to chronic pancreatitis in children: report from INSPPIRE. J Pediatr Gastroenterol Nutr. 2019; 69(2):206\u2013211.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"e_1_3_1_43_1","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1038\/ctg.2014.13","article-title":"The common chymotrypsinogen C (CTRC) variant G60G (C.180T) Increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population","volume":"6","author":"LaRusch J","year":"2015","unstructured":"LaRusch J, Lozano-Leon A, Stello K, et\u00a0al. The common chymotrypsinogen C (CTRC) variant G60G (C.180T) Increases risk of chronic pancreatitis but not recurrent acute pancreatitis in a North American population. Clin Transl Gastroenterol. 2015;6(1):e68\u2013e68.","journal-title":"Clin Transl Gastroenterol"},{"issue":"12","key":"e_1_3_1_44_1","first-page":"2051","article-title":"Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis","volume":"88","author":"Gumaste VV","year":"1993","unstructured":"Gumaste VV, Roditis N, Mehta D, et\u00a0al. Serum lipase levels in nonpancreatic abdominal pain versus acute pancreatitis. Am J Gastroenterol. 1993; 88(12):2051\u20132055.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"e_1_3_1_45_1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/MPG.0b013e31824f1516","article-title":"Definitions of pediatric pancreatitis and survey of present clinical practices","volume":"55","author":"Morinville VD","year":"2012","unstructured":"Morinville VD, Husain SZ, Bai H, Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr. 2012;55(3):261\u2013265.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"e_1_3_1_46_1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1542-3565(04)00013-8","article-title":"Clinical and genetic characteristics of hereditary pancreatitis in Europe","volume":"2","author":"Howes N","year":"2004","unstructured":"Howes N, Lerch MM, Greenhalf W, et\u00a0al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004; 2(3):252\u2013261.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10031","key":"e_1_3_1_47_1","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(16)00097-0","article-title":"Chronic pancreatitis","volume":"387","author":"Majumder S","year":"2016","unstructured":"Majumder S, Chari ST. Chronic pancreatitis. Lancet. 2016;387(10031):1957\u20131966.","journal-title":"Lancet"},{"issue":"1","key":"e_1_3_1_48_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/MPG.0000000000001446","article-title":"Causal evaluation of acute recurrent and chronic pancreatitis in children: consensus from the INSPPIRE group","volume":"64","author":"Gariepy CE","year":"2017","unstructured":"Gariepy CE, Heyman MB, Lowe ME, et\u00a0al. Causal evaluation of acute recurrent and chronic pancreatitis in children: consensus from the INSPPIRE group. J Pediatr Gastroenterol Nutr. 2017;64(1):95\u2013103.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"8","key":"e_1_3_1_49_1","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1097\/MPA.0000000000000237","article-title":"American pancreatic association practice guidelines in chronic pancreatitis: evidence-based report on diagnostic guidelines","volume":"43","author":"Conwell DL","year":"2014","unstructured":"Conwell DL, Lee LS, Yadav D, et\u00a0al. American pancreatic association practice guidelines in chronic pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014;43(8):1143\u20131162.","journal-title":"Pancreas"},{"issue":"5","key":"e_1_3_1_50_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000055840","article-title":"Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues","volume":"1","author":"Ellis I","year":"2001","unstructured":"Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology. 2001;1(5):405\u2013415.","journal-title":"Pancreatology"},{"key":"e_1_3_1_51_1","unstructured":"Goldstein A Falk MJ et\u00a0al. Mitochondrial DNA deletion syndromes. In: Adam MP Everman DB Mirzaa GM et al. editors. GeneReviews \u00ae [Internet]. Seattle (WA): University of Washington Seattle; 1993-2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1116\/."},{"issue":"6","key":"e_1_3_1_52_1","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-3476(79)80286-3","article-title":"A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction","volume":"95","author":"Pearson HA","year":"1979","unstructured":"Pearson HA, Lobel JS, Kocoshis SA, et\u00a0al. A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr. 1979; 95(6):976\u2013984.","journal-title":"J Pediatr"},{"issue":"3","key":"e_1_3_1_53_1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ajmg.a.36939","article-title":"Biochemical abnormalities in Pearson syndrome","volume":"167","author":"Crippa BL","year":"2015","unstructured":"Crippa BL, Leon E, Calhoun A, et\u00a0al. Biochemical abnormalities in Pearson syndrome. Am J Med Genet A. 2015; 167A(3):621\u2013628.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"e_1_3_1_54_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ymgme.2021.11.004","article-title":"Pediatric single large-scale mtDNA deletion syndromes: the power of patient reported outcomes","volume":"134","author":"Reynolds E","year":"2021","unstructured":"Reynolds E, Byrne M, Ganetzky R, et\u00a0al. Pediatric single large-scale mtDNA deletion syndromes: the power of patient reported outcomes. Mol Genet Metab. 2021; 134(4):301\u2013308.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"e_1_3_1_55_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ajmg.a.61433","article-title":"Broadening the phenotypic spectrum of pearson syndrome: five new cases and a review of the literature","volume":"182","author":"Wild KT","year":"2020","unstructured":"Wild KT, Goldstein AC, Muraresku C, et\u00a0al. Broadening the phenotypic spectrum of pearson syndrome: five new cases and a review of the literature. Am J Med Genet A. 2020;182(2):365\u2013373.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"e_1_3_1_56_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/brain\/awt321","article-title":"Disease progression in patients with single, large-scale mitochondrial DNA deletions","volume":"137","author":"Grady JP","year":"2014","unstructured":"Grady JP, Campbell G, Ratnaike T, et\u00a0al. Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain. 2014;137(Pt 2):323\u2013334.","journal-title":"Brain"},{"issue":"12","key":"e_1_3_1_57_1","doi-asserted-by":"crossref","first-page":"e15687","DOI":"10.1371\/journal.pone.0015687","article-title":"Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes","volume":"5","author":"Sadikovic B","year":"2010","unstructured":"Sadikovic B, Wang J, El-Hattab AW, et\u00a0al. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes. PLOS One. 2010; 5(12):e15687.","journal-title":"PLOS One"},{"key":"e_1_3_1_58_1","first-page":"37","article-title":"Pearson syndrome: a retrospective cohort study from the marrow failure study group of A.I.E.O.P","volume":"26","author":"Farruggia P","year":"2016","unstructured":"Farruggia P, Di Cataldo A, Pinto RM, et\u00a0al. Pearson syndrome: a retrospective cohort study from the marrow failure study group of A.I.E.O.P. Associazione Italiana Emato-Oncologia Pediatrica. JIMD Rep. 2016;26:37\u201343.","journal-title":"Associazione Italiana Emato-Oncologia Pediatrica. JIMD Rep"},{"issue":"5","key":"e_1_3_1_59_1","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1172\/JCI114881","article-title":"Pearson\u2019s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy","volume":"86","author":"Rotig A","year":"1990","unstructured":"Rotig A, Cormier V, Blanche S, et\u00a0al. Pearson\u2019s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy. J Clin Invest. 1990;86(5):1601\u20131608.","journal-title":"J Clin Invest"},{"issue":"7","key":"e_1_3_1_60_1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0009922819834285","article-title":"Pearson syndrome: a rare cause of failure to thrive in infants","volume":"58","author":"Pronman L","year":"2019","unstructured":"Pronman L, Rondinelli M, Burkardt DD, et\u00a0al. Pearson syndrome: a rare cause of failure to thrive in infants. Clin Pediatr . 2019; 58(7):819\u2013824.","journal-title":"Clin Pediatr"},{"issue":"3","key":"e_1_3_1_61_1","first-page":"143","article-title":"Therapeutic approach in a case of pearson\u2019s syndrome","volume":"57","author":"Zaffanello M","year":"2005","unstructured":"Zaffanello M, Zamboni G. Therapeutic approach in a case of pearson\u2019s syndrome. Minerva Pediatr. 2005; 57(3):143\u2013146.","journal-title":"Minerva Pediatr"},{"key":"e_1_3_1_62_1","doi-asserted-by":"crossref","first-page":"802402","DOI":"10.3389\/fgene.2022.802402","article-title":"Case report: clinical and genetic characteristics of pearson syndrome in a chinese boy and 139 patients","volume":"13","author":"Ying Y","year":"2022","unstructured":"Ying Y, Liang Y, Luo X, et\u00a0al. Case report: clinical and genetic characteristics of pearson syndrome in a chinese boy and 139 patients. Front Genet. 2022;13:802402.","journal-title":"Front Genet"},{"issue":"6","key":"e_1_3_1_63_1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0016-5085(96)70022-7","article-title":"Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression","volume":"111","author":"Mack DR","year":"1996","unstructured":"Mack DR, Forstner GG, Wilschanski M, et\u00a0al. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology. 1996;111(6):1593\u20131602.","journal-title":"Gastroenterology"},{"key":"e_1_3_1_64_1","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1651-2227.1964.tb07237.x","article-title":"Congenital hypoplasia of the exocrine pancreas","volume":"53","author":"Bodian M","year":"1964","unstructured":"Bodian M, Sheldon W, Lightwood R. Congenital hypoplasia of the exocrine pancreas. Acta Paediatr. 1964 May;53:282\u2013293.","journal-title":"Acta Paediatr"},{"issue":"6","key":"e_1_3_1_65_1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MPH.0b013e3182667c13","article-title":"Shwachman-Diamond syndrome: diarrhea, no longer required?","volume":"35","author":"Andolina JR","year":"2013","unstructured":"Andolina JR, Morrison CB, Thompson AA, et\u00a0al. Shwachman-Diamond syndrome: diarrhea, no longer required? J Pediatr Hematol Oncol. 2013; 35(6):486\u2013489.","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_3_1_66_1","volume-title":"Shwachman-Diamond syndrome. StatPearls","author":"Farooqui SM","year":"2022","unstructured":"Farooqui SM, Ward R, Aziz M. Shwachman-Diamond syndrome. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022."},{"issue":"5","key":"e_1_3_1_67_1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/humu.22538","article-title":"Mutations in the human UBR1 gene and the associated phenotypic spectrum","volume":"35","author":"Sukalo M","year":"2014","unstructured":"Sukalo M, Fiedler A, Guzm\u00e1n C, et\u00a0al. Mutations in the human UBR1 gene and the associated phenotypic spectrum. Hum Mutat. 2014;35(5):521\u2013531.","journal-title":"Hum Mutat"},{"issue":"2","key":"e_1_3_1_68_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ecl.2006.02.013","article-title":"Genetic basis and pancreatic biology of Johanson-Blizzard syndrome","volume":"35","author":"Zenker M","year":"2006","unstructured":"Zenker M, Mayerle J, Reis A, et\u00a0al. Genetic basis and pancreatic biology of Johanson-Blizzard syndrome. Endocrinol Metab Clin North Am. 2006; 35(2):243\u2013253.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"3","key":"e_1_3_1_69_1","first-page":"245","article-title":"Johanson-Blizzard syndrome. a new case with autopsy findings","volume":"12","author":"Vanlieferinghen PH","year":"2001","unstructured":"Vanlieferinghen PH, Borderon C, Francannet CH, et\u00a0al. Johanson-Blizzard syndrome. a new case with autopsy findings. Genet Couns. 2001;12(3):245\u2013250.","journal-title":"Genet Couns"},{"issue":"4","key":"e_1_3_1_70_1","first-page":"388","article-title":"Johanson-Blizzard syndrome: expanding the phenotype of exocrine pancreatic insufficiency","volume":"15","author":"Ellery KM","year":"2014","unstructured":"Ellery KM, Erdman SH. Johanson-Blizzard syndrome: expanding the phenotype of exocrine pancreatic insufficiency. JOP. 2014; 15(4):388\u2013390.","journal-title":"JOP"},{"issue":"4","key":"e_1_3_1_71_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cld.2018.06.001","article-title":"Alagille syndrome","volume":"22","author":"Mitchell E","year":"2018","unstructured":"Mitchell E, Gilbert M, Loomes KM. Alagille syndrome. Clin Liver Dis. 2018;22(4):625\u2013641.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"e_1_3_1_72_1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.hoc.2009.01.007","article-title":"Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment","volume":"23","author":"Burroughs L","year":"2009","unstructured":"Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am. 2009; 23(2):233\u2013248.","journal-title":"Hematol Oncol Clin North Am"},{"issue":"7","key":"e_1_3_1_73_1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00247-014-3231-6","article-title":"Shwachman-bodian-diamond syndrome: metaphyseal chondrodysplasia in children with pancreatic insufficiency and neutropenia","volume":"45","author":"Levin TL","year":"2015","unstructured":"Levin TL, M\u00e4kitie O, Berdon WE, et\u00a0al. Shwachman-bodian-diamond syndrome: metaphyseal chondrodysplasia in children with pancreatic insufficiency and neutropenia. Pediatr Radiol. 2015; 45(7):1066\u20131071.","journal-title":"Pediatr Radiol"},{"key":"e_1_3_1_74_1","doi-asserted-by":"crossref","first-page":"35229","DOI":"10.1038\/srep35229","article-title":"Exocrine pancreatic function in children with alagille syndrome","volume":"6","author":"Gliwicz D","year":"2016","unstructured":"Gliwicz D, Jankowska I, Wierzbicka A, et\u00a0al. Exocrine pancreatic function in children with alagille syndrome. Sci Rep. 2016; 6:35229.","journal-title":"Sci Rep"},{"issue":"5","key":"e_1_3_1_75_1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MPG.0b013e31825eff61","article-title":"Pancreatic insufficiency is not a prevalent problem in alagille syndrome","volume":"55","author":"Kamath BM","year":"2012","unstructured":"Kamath BM, Piccoli DA, Magee JC, et\u00a0al. Pancreatic insufficiency is not a prevalent problem in alagille syndrome. J Pediatr Gastroenterol Nutr. 2012;55(5):612\u2013614.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_3_1_76_1","unstructured":"Manoli I Sloan JL Venditti CP et\u00a0al. Isolated methylmalonic acidemia. In: Adam MP Everman DB Mirzaa GM et al. editors. GeneReviews \u00ae [Internet]. Seattle (WA): University of Washington Seattle; 1993-2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1116\/."},{"key":"e_1_3_1_77_1","unstructured":"Shchelochkov OA Carrillo N Venditti C et\u00a0al. Propionic acidemia. In: Adam MP Everman DB Mirzaa GM et al. editors. GeneReviews \u00ae [Internet]. Seattle (WA): University of Washington Seattle; 1993-2023. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1116\/."},{"key":"e_1_3_1_78_1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-014-0130-8","article-title":"Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia","volume":"9","author":"Baumgartner MR","year":"2014","unstructured":"Baumgartner MR, Horster F, Dionisi-Vici C, et\u00a0al. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis. 2014; 9:130.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"e_1_3_1_79_1","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MOP.0000000000000422","article-title":"Methylmalonic and propionic acidemias: clinical management update","volume":"28","author":"Fraser JL","year":"2016","unstructured":"Fraser JL, Venditti CP. Methylmalonic and propionic acidemias: clinical management update. Curr Opin Pediatr. 2016;28(6):682\u2013693.","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"e_1_3_1_80_1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/jimd.12370","article-title":"Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision","volume":"44","author":"Forny P","year":"2021","unstructured":"Forny P, Horster F, Ballhausen D, et\u00a0al. Guidelines for the diagnosis and management of methylmalonic acidaemia and propionic acidaemia: first revision. J Inherit Metab Dis. 2021;44(3):566\u2013592.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"e_1_3_1_81_1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1053\/j.gastro.2009.05.041","article-title":"Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats","volume":"137","author":"Bhoomagoud M","year":"2009","unstructured":"Bhoomagoud M, Jung T, Atladottir J, et\u00a0al. Reducing extracellular pH sensitizes the acinar cell to secretagogue-induced pancreatitis responses in rats. Gastroenterology. 2009; 137(3):1083\u20131092.","journal-title":"Gastroenterology"},{"issue":"2","key":"e_1_3_1_82_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3476(94)70311-6","article-title":"Pancreatitis in patients with organic acidemias","volume":"124","author":"Kahler SG","year":"1994","unstructured":"Kahler SG, Sherwood WG, Woolf D, et\u00a0al. Pancreatitis in patients with organic acidemias. J Pediatr. 1994;124(2):239\u2013243.","journal-title":"J Pediatr"},{"issue":"4","key":"e_1_3_1_83_1","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1096\/fj.08-121848","article-title":"Mitochondrial dysfunction in mut methylmalonic acidemia","volume":"23","author":"Chandler RJ","year":"2009","unstructured":"Chandler RJ, Zerfas PM, Shanske S, et\u00a0al. Mitochondrial dysfunction in mut methylmalonic acidemia. Faseb J. 2009;23(4):1252\u20131261.","journal-title":"Faseb J"},{"issue":"5","key":"e_1_3_1_84_1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s10545-012-9545-3","article-title":"Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia","volume":"36","author":"Gallego-Villar L","year":"2013","unstructured":"Gallego-Villar L, Perez-Cerda C, Perez B, et\u00a0al. Functional characterization of novel genotypes and cellular oxidative stress studies in propionic acidemia. J Inherit Metab Dis. 2013; 36(5):731\u2013740.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"e_1_3_1_85_1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/path.2248","article-title":"Methylmalonic acidaemia leads to increased production of reactive oxygen species and induction of apoptosis through the mitochondrial\/caspase pathway","volume":"213","author":"Richard E","year":"2007","unstructured":"Richard E, Alvarez-Barrientos A, Perez B, et\u00a0al. Methylmalonic acidaemia leads to increased production of reactive oxygen species and induction of apoptosis through the mitochondrial\/caspase pathway. J Pathol. 2007;213(4):453\u2013461.","journal-title":"J Pathol"},{"issue":"1","key":"e_1_3_1_86_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1042\/BJ20060221","article-title":"Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins","volume":"398","author":"Schwab MA","year":"2006","unstructured":"Schwab MA, Sauer SW, Okun JG, et\u00a0al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J. 2006;398(1):107\u2013112.","journal-title":"Biochem J"},{"issue":"1","key":"e_1_3_1_87_1","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ceca.2007.11.013","article-title":"Mitochondrial injury in pancreatitis","volume":"44","author":"Mukherjee R","year":"2008","unstructured":"Mukherjee R, Criddle DN, Gukovskaya A, et\u00a0al. Mitochondrial injury in pancreatitis. Cell Calcium. 2008; 44(1):14\u201323.","journal-title":"Cell Calcium"},{"issue":"6","key":"e_1_3_1_88_1","doi-asserted-by":"crossref","first-page":"1306S","DOI":"10.1093\/ajcn\/62.6.1306S","article-title":"Oxidative stress in acute and chronic pancreatitis","volume":"62","author":"Schoenberg MH","year":"1995","unstructured":"Schoenberg MH, Birk D, Beger HG. Oxidative stress in acute and chronic pancreatitis. Am J Clin Nutr. 1995;62(6 Suppl):1306S\u20131314S.","journal-title":"Am J Clin Nutr"},{"issue":"23","key":"e_1_3_1_89_1","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1002\/ajmg.a.32561","article-title":"Hyperamylasemia\/hyperlipasemia in a child with propionic acidemia","volume":"146","author":"Gilmore A","year":"2008","unstructured":"Gilmore A, Bock HG, Nowicki M. Hyperamylasemia\/hyperlipasemia in a child with propionic acidemia. Am J Med Genet A. 2008;146A(23):3090\u20133091.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"e_1_3_1_90_1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2011.08.034","article-title":"Chronic management and health supervision of individuals with propionic acidemia","volume":"105","author":"Sutton VR","year":"2012","unstructured":"Sutton VR, Chapman KA, Gropman AL, et\u00a0al. Chronic management and health supervision of individuals with propionic acidemia. Mol Genet Metab. 2012; 105(1):26\u201333.","journal-title":"Mol Genet Metab"},{"key":"e_1_3_1_91_1","volume-title":"Physiology, secretin","author":"DiGregorio N","year":"2022","unstructured":"DiGregorio N, Sharma S. Physiology, secretin. . Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022."},{"key":"e_1_3_1_92_1","volume-title":"Cholecystokinin test","author":"Jones MC","year":"2022","unstructured":"Jones MC, Vaqar S. Cholecystokinin test. . Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022."},{"issue":"2","key":"e_1_3_1_93_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1572-0241.2006.00398.x","article-title":"Where have all the dreiling tubes gone?","volume":"101","author":"Pollack BJ","year":"2006","unstructured":"Pollack BJ, Grendell JH. Where have all the dreiling tubes gone? Am J Gastroenterol. 2006; 101(2):356\u2013359.","journal-title":"Am J Gastroenterol"},{"issue":"24","key":"e_1_3_1_94_1","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1001\/jama.2019.19411","article-title":"Diagnosis and management of chronic pancreatitis: a review","volume":"322","author":"Singh VK","year":"2019","unstructured":"Singh VK, Yadav D, Garg PK. Diagnosis and management of chronic pancreatitis: a review. Jama. 2019; 322(24):2422\u20132434.","journal-title":"Jama"},{"issue":"5","key":"e_1_3_1_95_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4292\/wjgpt.v9.i5.39","article-title":"Challenges in the management of pancreatic exocrine insufficiency","volume":"9","author":"Shandro BM","year":"2018","unstructured":"Shandro BM, Nagarajah R, Poullis A. Challenges in the management of pancreatic exocrine insufficiency. World J Gastrointest Pharmacol Ther. 2018;9(5):39\u201346.","journal-title":"World J Gastrointest Pharmacol Ther"},{"issue":"1","key":"e_1_3_1_96_1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MPG.0000000000002931","article-title":"Endoscopic pancreatic function testing (ePFT) in children: a position paper from the NASPGHAN pancreas committee","volume":"72","author":"Patel N","year":"2021","unstructured":"Patel N, Sellers ZM, Grover A, et\u00a0al. Endoscopic pancreatic function testing (ePFT) in children: a position paper from the NASPGHAN pancreas committee. J Pediatr Gastroenterol Nutr. 2021;72(1):144\u2013150.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"e_1_3_1_97_1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/MPG.0000000000002230","article-title":"Assessment of exocrine pancreatic function during endoscopy in children","volume":"68","author":"Horvath K","year":"2019","unstructured":"Horvath K, Mehta DI, Hill ID. Assessment of exocrine pancreatic function during endoscopy in children. J Pediatr Gastroenterol Nutr. 2019;68(6):768\u2013776.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"e_1_3_1_98_1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MPG.0000000000002359","article-title":"A path to consensus on endoscopic pancreatic function testing","volume":"68","author":"Gelfond D.","year":"2019","unstructured":"Gelfond D. A path to consensus on endoscopic pancreatic function testing. J Pediatr Gastroenterol Nutr. 2019;68(6):761\u2013762.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"e_1_3_1_99_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/MPA.0000000000000724","article-title":"Utility of direct pancreatic function testing in children","volume":"46","author":"Alfaro Cruz L","year":"2017","unstructured":"Alfaro Cruz L, Parniczky A, Mayhew A, et\u00a0al. Utility of direct pancreatic function testing in children. Pancreas. 2017;46(2):177\u2013182.","journal-title":"Pancreas"},{"issue":"5","key":"e_1_3_1_100_1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/MPA.0000000000001540","article-title":"Report on the short endoscopic exocrine pancreatic function test in children and young adults","volume":"49","author":"Mehta DI","year":"2020","unstructured":"Mehta DI, He Z, Bornstein J, et\u00a0al. Report on the short endoscopic exocrine pancreatic function test in children and young adults. Pancreas. 2020;49(5):642\u2013649.","journal-title":"Pancreas"},{"issue":"7","key":"e_1_3_1_101_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrgastro.2011.91","article-title":"The role of fecal elastase-1 in detecting exocrine pancreatic disease","volume":"8","author":"Leeds JS","year":"2011","unstructured":"Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011;8(7):405\u2013415.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"e_1_3_1_102_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4314\/wajm.v23i3.28130","article-title":"Faecal pancreatic elastase\u20131 a non invasive measure of exocrine pancreatic function","volume":"23","author":"Amanquah SD","year":"2004","unstructured":"Amanquah SD, Darko R, Maddy SQ, et\u00a0al. Faecal pancreatic elastase\u20131 a non invasive measure of exocrine pancreatic function. West Afr J Med. 2004;23(3):240\u2013244.","journal-title":"West Afr J Med"},{"issue":"7","key":"e_1_3_1_103_1","doi-asserted-by":"crossref","first-page":"e0159363","DOI":"10.1371\/journal.pone.0159363","article-title":"Specificity of a polyclonal fecal elastase ELISA for CELA3","volume":"11","author":"Weiss FU","year":"2016","unstructured":"Weiss FU, Budde C, Lerch MM. Specificity of a polyclonal fecal elastase ELISA for CELA3. PLOS One. 2016;11(7):e0159363.","journal-title":"PLOS One"},{"issue":"5","key":"e_1_3_1_104_1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s10620-017-4524-z","article-title":"Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test","volume":"62","author":"Dom\u00ednguez-Mu\u00f1oz JE","year":"2017","unstructured":"Dom\u00ednguez-Mu\u00f1oz JE, Dh P, Lerch MM, et\u00a0al. Potential for screening for pancreatic exocrine insufficiency using the fecal elastase-1 test. Dig Dis Sci. 2017;62(5):1119\u20131130.","journal-title":"Dig Dis Sci"},{"issue":"3","key":"e_1_3_1_105_1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.pcl.2017.01.010","article-title":"Pancreatic disorders","volume":"64","author":"Uc A","year":"2017","unstructured":"Uc A, Fishman DS. Pancreatic disorders. Pediatr Clin North Am. 2017;64(3):685\u2013706.","journal-title":"Pediatr Clin North Am"},{"issue":"4","key":"e_1_3_1_106_1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/gut.39.4.580","article-title":"Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test","volume":"39","author":"L\u00f6ser C","year":"1996","unstructured":"L\u00f6ser C, M\u00f6llgaard A, F\u00f6lsch UR. Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut. 1996;39(4):580\u2013586.","journal-title":"Gut"},{"issue":"2","key":"e_1_3_1_107_1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/00365529950173104","article-title":"Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis","volume":"34","author":"Walkowiak J","year":"1999","unstructured":"Walkowiak J, Cichy WK, Herzig KH. Comparison of fecal elastase-1 determination with the secretin-cholecystokinin test in patients with cystic fibrosis. Scand J Gastroenterol. 1999; 34(2):202\u2013207.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"e_1_3_1_108_1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/MPG.0b013e31820b0227","article-title":"Comparison of fecal elastase-1 and pancreatic function testing in children","volume":"54","author":"Wali PD","year":"2012","unstructured":"Wali PD, Loveridge-Lenza B, He Z, et\u00a0al. Comparison of fecal elastase-1 and pancreatic function testing in children. J Pediatr Gastroenterol Nutr. 2012;54(2):277\u2013280.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"e_1_3_1_109_1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1569-1993(02)00097-8","article-title":"Variability of fecal pancreatic elastase measurements in cystic fibrosis patients","volume":"1","author":"Meyts I","year":"2002","unstructured":"Meyts I, Wuyts W, Proesmans M, et\u00a0al. Variability of fecal pancreatic elastase measurements in cystic fibrosis patients. J Cyst Fibros. 2002;1(4):265\u2013268.","journal-title":"J Cyst Fibros"},{"issue":"8","key":"e_1_3_1_110_1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.cgh.2018.01.027","article-title":"Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: Systematic review and meta-analysis","volume":"16","author":"Vanga RR","year":"2018","unstructured":"Vanga RR, Tansel A, Sidiq S, et\u00a0al. Diagnostic performance of measurement of fecal elastase-1 in detection of exocrine pancreatic insufficiency: Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(8):1220\u20131228.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"e_1_3_1_111_1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1067\/mpd.2002.124829","article-title":"How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease?","volume":"141","author":"Beharry S","year":"2002","unstructured":"Beharry S, Ellis L, Corey M, et\u00a0al. How useful is fecal pancreatic elastase 1 as a marker of exocrine pancreatic disease? J Pediatr. 2002;141(1):84\u201390.","journal-title":"J Pediatr"},{"issue":"4","key":"e_1_3_1_112_1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/MPG.0000000000002267","article-title":"Transient exocrine pancreatic insufficiency in children: an existing entity?","volume":"68","author":"Garah J","year":"2019","unstructured":"Garah J, Rosen I, Shaoul R. Transient exocrine pancreatic insufficiency in children: an existing entity? J Pediatr Gastroenterol Nutr. 2019; Apr68(4):574\u2013577.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"e_1_3_1_113_1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/MPA.0000000000002006","article-title":"Clinical and analytical characterization of the DiaSorin and ScheBo fecal pancreatic elastase 1 assays","volume":"51","author":"Wyness SP","year":"2022","unstructured":"Wyness SP, Nelson HA, Jensen R, et\u00a0al. Clinical and analytical characterization of the DiaSorin and ScheBo fecal pancreatic elastase 1 assays. Pancreas. 2022; Mar 151(3):243\u2013249.","journal-title":"Pancreas"},{"issue":"1","key":"e_1_3_1_114_1","first-page":"S27","article-title":"Management of exocrine pancreatic insufficiency in children","volume":"34","author":"Sankararaman S","year":"2019","unstructured":"Sankararaman S, Schindler T, Sferra TJ. Management of exocrine pancreatic insufficiency in children. Nutr Clin Pract. 2019;34 Suppl 1(Suppl 1):S27\u2013s42.","journal-title":"Nutr Clin Pract"},{"issue":"3","key":"e_1_3_1_115_1","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.clnu.2016.03.004","article-title":"ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis","volume":"35","author":"Turck D","year":"2016","unstructured":"Turck D, Braegger CP, Colombo C, et\u00a0al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin Nutr. 2016;35(3):557\u2013577.","journal-title":"Clin Nutr"},{"issue":"5","key":"e_1_3_1_116_1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/MPG.0b013e31827fb091","article-title":"Protracted maturation of pancreatic-specific elastase 1 excretion in preterm infants of extremely low gestational age","volume":"56","author":"M\u00fcnch A","year":"2013","unstructured":"M\u00fcnch A, Garten L, B\u00fchrer C. Protracted maturation of pancreatic-specific elastase 1 excretion in preterm infants of extremely low gestational age. J Pediatr Gastroenterol Nutr. 2013;56(5):532\u2013536.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"5","key":"e_1_3_1_117_1","first-page":"549","article-title":"Fecal pancreatic elastase in infants under 2 years of age","volume":"66","author":"Benahmed NA","year":"2008","unstructured":"Benahmed NA, Manene D, Barbot L, et\u00a0al. Fecal pancreatic elastase in infants under 2 years of age. Ann Biol Clin. 2008;66(5):549\u2013552.","journal-title":"Ann Biol Clin"},{"issue":"2","key":"e_1_3_1_118_1","first-page":"123","article-title":"Fecal elastase-1 in healthy children up to 2 years of age: a cross-sectional study","volume":"22","author":"Wieczorek-Filipiak M","year":"2018","unstructured":"Wieczorek-Filipiak M, Drzyma\u0142a-Czy\u017c S, Szczepanik M, et\u00a0al. Fecal elastase-1 in healthy children up to 2 years of age: a cross-sectional study. Dev Period Med. 2018;22(2):123\u2013127.","journal-title":"Dev Period Med"},{"issue":"2","key":"e_1_3_1_119_1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/MPG.0b013e31826f2b71","article-title":"Comparison of diagnostic methods for pancreatic insufficiency in infants with cystic fibrosis","volume":"56","author":"Tardelli AC","year":"2013","unstructured":"Tardelli AC, Camargos PA, Penna FJ, et\u00a0al. Comparison of diagnostic methods for pancreatic insufficiency in infants with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2013; 56(2):178\u2013181.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"e_1_3_1_120_1","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00431-021-04069-0","article-title":"Digestive enzyme replacement relieves growth failure in preterm infants with poor exocrine pancreatic function: a retrospective case series","volume":"180","author":"M\u00fcnch A","year":"2021","unstructured":"M\u00fcnch A, B\u00fchrer C, Longardt AC. Digestive enzyme replacement relieves growth failure in preterm infants with poor exocrine pancreatic function: a retrospective case series. Eur J Pediatr. 2021;180(9):2951\u20132958.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"e_1_3_1_121_1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1373\/clinchem.2004.046888","article-title":"Monoclonal versus polyclonal ELISA for assessment of fecal elastase concentration: pitfalls of a new assay","volume":"51","author":"Schneider A","year":"2005","unstructured":"Schneider A, Funk B, Caspary W, et\u00a0al. Monoclonal versus polyclonal ELISA for assessment of fecal elastase concentration: pitfalls of a new assay. Clin Chem. 2005; 51(6):1052\u20131054.","journal-title":"Clin Chem"},{"key":"e_1_3_1_122_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinbiochem.2022.05.002","article-title":"Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results","volume":"107","author":"Johnson LM","year":"2022","unstructured":"Johnson LM, Spannagl M, Wojtalewicz N, et\u00a0al. Comparison of fecal calprotectin and pancreatic elastase assays based on proficiency testing results. Clin Biochem. 2022;107:19\u201323.","journal-title":"Clin Biochem"},{"issue":"4","key":"e_1_3_1_123_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/gut.42.4.551","article-title":"Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency","volume":"42","author":"Lankisch PG","year":"1998","unstructured":"Lankisch PG, Schmidt I, K\u00f6nig H, et\u00a0al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut. 1998;42(4):551\u2013554.","journal-title":"Gut"},{"issue":"3","key":"e_1_3_1_124_1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s11938-018-0186-y","article-title":"Diagnosis and management of exocrine pancreatic insufficiency","volume":"16","author":"Forsmark CE.","year":"2018","unstructured":"Forsmark CE. Diagnosis and management of exocrine pancreatic insufficiency. Curr Treat Options Gastroenterol. 2018; 16(3):306\u2013315.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"3","key":"e_1_3_1_125_1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1258\/0004563011900605","article-title":"Faecal fat: time to give it up","volume":"38","author":"Hill PG.","year":"2001","unstructured":"Hill PG. Faecal fat: time to give it up. Ann Clin Biochem. 2001; 38(Pt 3):164\u2013167.","journal-title":"Ann Clin Biochem"},{"issue":"8894","key":"e_1_3_1_126_1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(94)91220-3","article-title":"Colon as a digestive organ in patients with short bowel","volume":"343","author":"Nordgaard I","year":"1994","unstructured":"Nordgaard I, Hansen BS, Mortensen PB. Colon as a digestive organ in patients with short bowel. Lancet. 1994;343(8894):373\u2013376.","journal-title":"Lancet"},{"issue":"2","key":"e_1_3_1_127_1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MPG.0000000000002199","article-title":"Fecal fat concentration and excretion in the first 2 years of life: a cross-sectional study","volume":"68","author":"Wieczorek-Filipiak M","year":"2019","unstructured":"Wieczorek-Filipiak M, Drzyma\u0142a-Czy\u017c S, Szczepanik M, et\u00a0al. Fecal fat concentration and excretion in the first 2 years of life: a cross-sectional study. J Pediatr Gastroenterol Nutr. 2019;68(2):285\u2013289.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"e_1_3_1_128_1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/MPG.0b013e3182281c38","article-title":"Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency","volume":"53","author":"Caras S","year":"2011","unstructured":"Caras S, Boyd D, Zipfel L, et\u00a0al. Evaluation of stool collections to measure efficacy of PERT in subjects with exocrine pancreatic insufficiency. J Pediatr Gastroenterol Nutr. 2011;53(6):634\u2013640.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_3_1_129_1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM196101122640207","article-title":"Microscopical examination of the stool for steatorrhea","volume":"264","author":"Drummey GD","year":"1961","unstructured":"Drummey GD, Benson JA, Jr., Jones CM. Microscopical examination of the stool for steatorrhea. N Engl J Med. 1961; 264:85\u201387.","journal-title":"N Engl J Med"},{"key":"e_1_3_1_130_1","volume-title":"Clinical microbiology procedures handbook","author":"Leber A","year":"2016","unstructured":"9.5.7 Qualitative fecal fat. 4th ed. Leber A, editor. Clinical microbiology procedures handbook Washington, DC: ASM Press; 2016. .","edition":"4"},{"issue":"4","key":"e_1_3_1_131_1","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/0T2W-NN7F-7T8Q-5N8C","article-title":"A new method of quantitative fecal fat microscopy and its correlation with chemically measured fecal fat output","volume":"13","author":"Fine KD","year":"2000","unstructured":"Fine KD, Ogunji F. A new method of quantitative fecal fat microscopy and its correlation with chemically measured fecal fat output. Am J Clin Pathol. 2000;13(4):528\u2013534.","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"e_1_3_1_132_1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1042\/bj0610180","article-title":"Quantitative determination of the different higher saturated fatty acids in fat from blood, chyle and faeces, by means of partition chromatography on rubber","volume":"61","author":"Van De Kamer JH","year":"1955","unstructured":"Van De Kamer JH, Pikaar NA, Bolssens-Frankena A, et\u00a0al. Quantitative determination of the different higher saturated fatty acids in fat from blood, chyle and faeces, by means of partition chromatography on rubber. Biochem J. 1955; 61(2):180\u2013186.","journal-title":"Biochem J"},{"issue":"1","key":"e_1_3_1_133_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2008.10.001","article-title":"Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetry","volume":"400","author":"Korpi-Steiner NL","year":"2009","unstructured":"Korpi-Steiner NL, Ward JN, Kumar V, et\u00a0al. Comparative analysis of fecal fat quantitation via nuclear magnetic resonance spectroscopy (1H NMR) and gravimetry. Clin Chim Acta. 2009; 400(1\u20132):33\u201336.","journal-title":"Clin Chim Acta"},{"key":"e_1_3_1_134_1","first-page":"2187","volume-title":"Tietz textbook of clinical chemistry","author":"Burtis CA","year":"1991","unstructured":"Appendix: reference intervals. In: Burtis CA, ER, editor. Tietz textbook of clinical chemistry. 2nd ed. Philadelphia, PA: w. B. Saunders and Company; 1991. p. 2187.","edition":"2"},{"issue":"4","key":"e_1_3_1_135_1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/jn\/54.4.491","article-title":"Fat excretion: the influence of dietary fat on fecal fat excretion","volume":"54","author":"Norcia LN","year":"1954","unstructured":"Norcia LN, Lundberg WO. Fat excretion: the influence of dietary fat on fecal fat excretion. J Nutr. 1954;54(4):491\u2013508.","journal-title":"J Nutr"},{"issue":"4","key":"e_1_3_1_136_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3476(87)80108-7","article-title":"Taurine supplementation, fat absorption, and growth in cystic fibrosis","volume":"111","author":"Thompson GN","year":"1987","unstructured":"Thompson GN, Robb TA, Davidson GP. Taurine supplementation, fat absorption, and growth in cystic fibrosis. J Pediatr. 1987;111(4):501\u2013506.","journal-title":"J Pediatr"},{"issue":"3","key":"e_1_3_1_137_1","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/adc.65.3.294","article-title":"Persistent diarrhoea: clinical efficacy and nutrient absorption with a rice based diet","volume":"65","author":"Roy SK","year":"1990","unstructured":"Roy SK, Haider R, Akbar MS, et\u00a0al. Persistent diarrhoea: clinical efficacy and nutrient absorption with a rice based diet. Arch Dis Child. 1990;65(3):294\u2013297.","journal-title":"Arch Dis Child"},{"issue":"4","key":"e_1_3_1_138_1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MPA.0000000000002016","article-title":"Coefficient of fat absorption to measure the efficacy of pancreatic enzyme replacement therapy in people with cystic fibrosis: gold standard or coal standard?","volume":"51","author":"Borowitz D","year":"2022","unstructured":"Borowitz D, Aronoff N, Cummings LC, et\u00a0al. Coefficient of fat absorption to measure the efficacy of pancreatic enzyme replacement therapy in people with cystic fibrosis: gold standard or coal standard? Pancreas. 2022;51(4):310\u2013318.","journal-title":"Pancreas"},{"issue":"6","key":"e_1_3_1_139_1","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/adc.65.6.594","article-title":"Two enteric coated microspheres in cystic fibrosis","volume":"65","author":"Williams J","year":"1990","unstructured":"Williams J, MacDonald A, Weller PH, et\u00a0al. Two enteric coated microspheres in cystic fibrosis. Arch Dis Child. 1990;65(6):594\u2013597.","journal-title":"Arch Dis Child"},{"issue":"4","key":"e_1_3_1_140_1","first-page":"287","article-title":"Creon 10,000 minimicrospheres vs","volume":"1","author":"Patchell CJ","year":"2002","unstructured":"Patchell CJ, Desai M, Weller PH, et\u00a0al. Creon 10,000 minimicrospheres vs. J Cyst Fibros. 2002; 1(4):287\u2013291.","journal-title":"J Cyst Fibros"},{"key":"e_1_3_1_141_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.acc.2021.09.008","article-title":"Screening for gastrointestinal and pancreatic diseases","volume":"108","author":"Johnson L.","year":"2022","unstructured":"Johnson L. Screening for gastrointestinal and pancreatic diseases. Adv Clin Chem. 2022;108:129\u2013153.","journal-title":"Adv Clin Chem"},{"key":"e_1_3_1_142_1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/8904_2011_55","article-title":"Cystic fibrosis newborn screening: distribution of blood immunoreactive trypsinogen concentrations in hypertrypsinemic neonates","volume":"4","author":"Paracchini V","year":"2012","unstructured":"Paracchini V, Seia M, Raimondi S, et\u00a0al. Cystic fibrosis newborn screening: distribution of blood immunoreactive trypsinogen concentrations in hypertrypsinemic neonates. JIMD Rep. 2012;4:17\u201323.","journal-title":"JIMD Rep"},{"issue":"4","key":"e_1_3_1_143_1","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2018.02.029","article-title":"Acute pancreatitis guideline","volume":"154","author":"Crockett S","year":"2018","unstructured":"Crockett S, Falck-Ytter Y, Wani S, et\u00a0al. Acute pancreatitis guideline. Gastroenterology. 2018; 154(4):1102.","journal-title":"Gastroenterology"},{"issue":"2","key":"e_1_3_1_144_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00451906","article-title":"Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis","volume":"144","author":"Bollbach R","year":"1985","unstructured":"Bollbach R, Becker M, Rotthauwe HW. Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis. Eur J Pediatr. 1985;144(2):167\u2013170.","journal-title":"Eur J Pediatr"},{"issue":"6","key":"e_1_3_1_145_1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archpedi.1984.02140440061016","article-title":"Cystic fibrosis serum pancreatic amylase","volume":"138","author":"Gillard BK","year":"1984","unstructured":"Gillard BK, Cox KL, Pollack PA, et\u00a0al. Cystic fibrosis serum pancreatic amylase. Am J Dis Child. 1984;138(6):577\u2013580.","journal-title":"Am J Dis Child"},{"issue":"1","key":"e_1_3_1_146_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2011.06349.x","article-title":"Draft consensus guidelines for diagnosis and treatment of Shwachman-diamond syndrome","volume":"1242","author":"Dror Y","year":"2011","unstructured":"Dror Y, Donadieu J, Koglmeier J, et\u00a0al. Draft consensus guidelines for diagnosis and treatment of Shwachman-diamond syndrome. Ann N Y Acad Sci. 2011;1242(1):40\u201355.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"e_1_3_1_147_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF01536152","article-title":"Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease","volume":"34","author":"Ventrucci M","year":"1989","unstructured":"Ventrucci M, Pezzilli R, Gullo L, et\u00a0al. Role of serum pancreatic enzyme assays in diagnosis of pancreatic disease. Dig Dis Sci. 1989;34(1):39\u201345.","journal-title":"Dig Dis Sci"},{"issue":"20","key":"e_1_3_1_148_1","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJM198405173102007","article-title":"Trypsin-like immunoreactivity as a test for pancreatic insufficiency","volume":"310","author":"Jacobson DG","year":"1984","unstructured":"Jacobson DG, Curington C, Connery K, et\u00a0al. Trypsin-like immunoreactivity as a test for pancreatic insufficiency. N Engl J Med. 1984;310(20):1307\u20131309.","journal-title":"N Engl J Med"},{"issue":"11","key":"e_1_3_1_149_1","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1136\/gut.27.11.1362","article-title":"Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis","volume":"27","author":"Moore DJ","year":"1986","unstructured":"Moore DJ, Forstner GG, Largman C, et\u00a0al. Serum immunoreactive cationic trypsinogen: a useful indicator of severe exocrine dysfunction in the paediatric patient without cystic fibrosis. Gut. 1986;27(11):1362\u20131368.","journal-title":"Gut"},{"key":"e_1_3_1_150_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/CEG.S168266","article-title":"Exocrine pancreatic insufficiency: prevalence, diagnosis, and management","volume":"12","author":"Capurso G","year":"2019","unstructured":"Capurso G, Traini M, Piciucchi M, et\u00a0al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129\u2013139.","journal-title":"Clin Exp Gastroenterol"},{"issue":"3","key":"e_1_3_1_151_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1542\/peds.77.3.301","article-title":"Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis","volume":"77","author":"Cleghorn G","year":"1986","unstructured":"Cleghorn G, Benjamin L, Corey M, et\u00a0al. Serum immunoreactive pancreatic lipase and cationic trypsinogen for the assessment of exocrine pancreatic function in older patients with cystic fibrosis. Pediatrics. 1986;77(3):301\u2013306.","journal-title":"Pediatrics"},{"key":"e_1_3_1_152_1","unstructured":"Schumann G Aoki R Ferrero C et\u00a0al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37\u2009\u00b0C. Part 8. Reference procedure for the measurement of catalytic concentration of alpha-amylase [alpha-Amylase: 1 4-alpha-D-glucan 4-glucanohydrolase (AMY) EC 3.2.1.1]. 2006. 01\/01."},{"issue":"1","key":"e_1_3_1_153_1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/clinchem\/35.1.110","article-title":"Pancreatic amylase measured in serum by use of a monoclonal antibody immunochemically immobilized to a solid phase","volume":"35","author":"Mifflin TE","year":"1989","unstructured":"Mifflin TE, Hamilton M, Hubbard E, et\u00a0al. Pancreatic amylase measured in serum by use of a monoclonal antibody immunochemically immobilized to a solid phase. Clin Chem. 1989; 35(1):110\u2013114.","journal-title":"Clin Chem"},{"issue":"4","key":"e_1_3_1_154_1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1258\/0004563011900876","article-title":"Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate","volume":"38","author":"Panteghini M","year":"2001","unstructured":"Panteghini M, Bonora R, Pagani F. Measurement of pancreatic lipase activity in serum by a kinetic colorimetric assay using a new chromogenic substrate. Ann Clin Biochem: Int J Lab Med. 2001;38(4):365\u2013370.","journal-title":"Ann Clin Biochem: Int J Lab Med"},{"key":"e_1_3_1_155_1","first-page":"1","article-title":"Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs","volume":"53","author":"Grosse S","year":"2004","unstructured":"Grosse S, Boyle C, Botkin J, et\u00a0al. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. Morb Monthly Wkly Rep. 2004;53:1\u201337.","journal-title":"Morb Monthly Wkly Rep"},{"issue":"0","key":"e_1_3_1_156_1","doi-asserted-by":"crossref","first-page":"232640981666135","DOI":"10.1177\/2326409816661358","article-title":"Newborn screening quality assurance program for CFTR mutation detection and gene sequencing to identify cystic fibrosis","volume":"4","author":"Hendrix MM","year":"2016","unstructured":"Hendrix MM, Foster SL, Cordovado SK. Newborn screening quality assurance program for CFTR mutation detection and gene sequencing to identify cystic fibrosis. J Inborn Errors Metab Screen. 2016;4(0):232640981666135.","journal-title":"J Inborn Errors Metab Screen"},{"issue":"1","key":"e_1_3_1_157_1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2006.05.008","article-title":"A survey of newborn screening for cystic fibrosis in Europe","volume":"6","author":"Southern KW","year":"2007","unstructured":"Southern KW, Munck A, Pollitt R, et\u00a0al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros. 2007;6(1):57\u201365.","journal-title":"J Cyst Fibros"},{"issue":"2","key":"e_1_3_1_158_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1258\/096914106777589623","article-title":"Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen","volume":"13","author":"Li L","year":"2006","unstructured":"Li L, Zhou Y, Bell CJ, et\u00a0al. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen. J Med Screen. 2006;13(2):79\u201384.","journal-title":"J Med Screen"},{"issue":"4","key":"e_1_3_1_159_1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.7326\/0003-4819-97-4-549","article-title":"Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency","volume":"97","author":"Dutta SK","year":"1982","unstructured":"Dutta SK, Bustin MP, Russell RM, et\u00a0al. Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med. 1982;97(4):549\u2013552.","journal-title":"Ann Intern Med"},{"key":"e_1_3_1_160_1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.pan.2015.07.001","article-title":"Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: prevalence and diagnostic use","volume":"15","author":"Lindkvist B","year":"2015","unstructured":"Lindkvist B, MP, Dom\u00ednguez-Munoz JE. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: prevalence and diagnostic use. Pancreatology. 2015;15:589\u2013597.","journal-title":"Pancreatology"},{"issue":"8","key":"e_1_3_1_161_1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MPA.0000000000001137","article-title":"Exocrine pancreatic insufficiency and malnutrition in chronic pancreatitis","volume":"47","author":"Min M","year":"2018","unstructured":"Min M, Patel B, Han S, et\u00a0al. Exocrine pancreatic insufficiency and malnutrition in chronic pancreatitis. Pancreas. 2018;47(8):1015\u20131018.","journal-title":"Pancreas"},{"issue":"3","key":"e_1_3_1_162_1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pan.2013.02.008","article-title":"The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis","volume":"13","author":"Sikkens ECM","year":"2013","unstructured":"Sikkens ECM, Cahen DL, Koch A, et\u00a0al. The prevalence of fat-soluble vitamin deficiencies and a decreased bone mass in patients with chronic pancreatitis. Pancreatology. 2013;13(3):238\u2013242.","journal-title":"Pancreatology"},{"issue":"1","key":"e_1_3_1_163_1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MPG.0000000000002023","article-title":"Nutritional considerations in pediatric pancreatitis: a position paper from the NASPGHAN pancreas committee and ESPGHAN cystic fibrosis\/pancreas working group","volume":"67","author":"Abu-El-Haija M","year":"2018","unstructured":"Abu-El-Haija M, Uc A, Werlin SL, et\u00a0al. Nutritional considerations in pediatric pancreatitis: a position paper from the NASPGHAN pancreas committee and ESPGHAN cystic fibrosis\/pancreas working group. J Pediatr Gastroenterol Nutr. 2018;67(1):131\u2013143.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"e_1_3_1_164_1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005176-200209000-00004","article-title":"Consensus report on nutrition for pediatric patients with cystic fibrosis","volume":"35","author":"Borowitz D","year":"2002","unstructured":"Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002;35(3):246\u2013259.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"e_1_3_1_165_1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jpba.2006.03.037","article-title":"HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma","volume":"42","author":"Karpi\u0144ska J","year":"2006","unstructured":"Karpi\u0144ska J, Miko\u0142u\u0107 B, Motkowski R, et\u00a0al. HPLC method for simultaneous determination of retinol, alpha-tocopherol and coenzyme Q10 in human plasma. J Pharm Biomed Anal. 2006; 42(2):232\u2013236.","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"e_1_3_1_166_1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jchromb.2009.02.051","article-title":"Isocratic rapid liquid chromatographic method for simultaneous determination of carotenoids, retinol, and tocopherols in human serum","volume":"877","author":"Thibeault D","year":"2009","unstructured":"Thibeault D, Su H, MacNamara E, et\u00a0al. Isocratic rapid liquid chromatographic method for simultaneous determination of carotenoids, retinol, and tocopherols in human serum. J Chromatogr B Analyt Technol Biomed Life Sci. 2009; 877(11\u201312):1077\u20131083.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"2","key":"e_1_3_1_167_1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00216-011-5447-8","article-title":"Preparation and value assignment of standard reference material 968e fat-soluble vitamins, caretenoids, and cholesterol in human serum","volume":"402","author":"Thomas JB","year":"2012","unstructured":"Thomas JB, Duewer DL, Burdette CQ, et\u00a0al. Preparation and value assignment of standard reference material 968e fat-soluble vitamins, caretenoids, and cholesterol in human serum. Anal Bioanal Chem. 2012;402(2):749\u2013762.","journal-title":"Anal Bioanal Chem"},{"issue":"7","key":"e_1_3_1_168_1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/neu.20242","article-title":"Overview of retinoid metabolism and function","volume":"66","author":"Blomhoff R","year":"2006","unstructured":"Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66(7):606\u2013630.","journal-title":"J Neurobiol"},{"issue":"11","key":"e_1_3_1_169_1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jchromb.2009.02.063","article-title":"Evaluation of uncertainty of measurement from method validation data: an application to the simultaneous determination of retinol and \u03b1-tocopherol in human serum by HPLC","volume":"877","author":"Semeraro A","year":"2009","unstructured":"Semeraro A, Altieri I, Patriarca M, et\u00a0al. Evaluation of uncertainty of measurement from method validation data: an application to the simultaneous determination of retinol and \u03b1-tocopherol in human serum by HPLC. J Chromatogr B. 2009;877(11):1209\u20131215.","journal-title":"J Chromatogr B"},{"issue":"17","key":"e_1_3_1_170_1","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jssc.201301373","article-title":"Fast, simple, and sensitive high-performance liquid chromatography method for measuring vitamins a and E in human blood plasma","volume":"37","author":"Yuan C","year":"2014","unstructured":"Yuan C, Burgyan M, Bunch DR, et\u00a0al. Fast, simple, and sensitive high-performance liquid chromatography method for measuring vitamins a and E in human blood plasma. J Sep Sci. 2014;37(17):2293\u20132299.","journal-title":"J Sep Sci"},{"issue":"6","key":"e_1_3_1_171_1","doi-asserted-by":"crossref","first-page":"1689S","DOI":"10.1093\/ajcn\/80.6.1689S","article-title":"Overview of general physiologic features and functions of vitamin D","volume":"80","author":"DeLuca HF.","year":"2004","unstructured":"DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004;80(6 Suppl):1689S\u20131696S.","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"e_1_3_1_172_1","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline","volume":"96","author":"Holick MF","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, et\u00a0al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911\u20131930.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"e_1_3_1_173_1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/aje\/kwx297","article-title":"Measurement of vitamin D for epidemiologic and clinical research: Shining light on a complex decision","volume":"187","author":"Jukic AMZ","year":"2018","unstructured":"Jukic AMZ, Hoofnagle AN, Lutsey PL. Measurement of vitamin D for epidemiologic and clinical research: Shining light on a complex decision. Am J Epidemiol. 2018;187(4):879\u2013890.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_1_174_1","first-page":"32","article-title":"Vitamin D status as an international issue: national surveys and the problem of standardization","volume":"243","author":"Sempos CT","year":"2012","unstructured":"Sempos CT, Vesper HW, Phinney KW, et\u00a0al. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl. 2012;243:32\u201340.","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"3","key":"e_1_3_1_175_1","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1194\/jlr.R045559","article-title":"Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis","volume":"55","author":"Shearer MJ","year":"2014","unstructured":"Shearer MJ, Newman P. Recent trends in the metabolism and cell biology of vitamin K with special reference to vitamin K cycling and MK-4 biosynthesis. J Lipid Res. 2014;55(3):345\u2013362.","journal-title":"J Lipid Res"},{"issue":"2","key":"e_1_3_1_176_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1569-1993(03)00025-0","article-title":"Assessment of vitamin K deficiency in CF\u2014how much sophistication is useful?","volume":"2","author":"Mosler K","year":"2003","unstructured":"Mosler K, Von Kries R, Vermeer C, et\u00a0al. Assessment of vitamin K deficiency in CF\u2014how much sophistication is useful? J Cyst Fibros. 2003;2(2):91\u201396.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"e_1_3_1_177_1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/cclm-2016-0783","article-title":"Vitamin K plasma levels determination in human health","volume":"55","author":"Fusaro M","year":"2017","unstructured":"Fusaro M, Gallieni M, Rizzo M, et\u00a0al. Vitamin K plasma levels determination in human health. Clin Chem Lab Med. 2017;55(6):789\u2013799.","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"e_1_3_1_178_1","first-page":"18S","article-title":"Functional roles of fatty acids and their effects on human health","volume":"39","author":"Calder PC.","year":"2015","unstructured":"Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr. 2015;39(1 Suppl):18S\u201332S.","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"6","key":"e_1_3_1_179_1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/jpen.1537","article-title":"Essential fatty acid requirements and intravenous lipid emulsions","volume":"43","author":"Gramlich L","year":"2019","unstructured":"Gramlich L, Ireton-Jones C, Miles JM, et\u00a0al. Essential fatty acid requirements and intravenous lipid emulsions. JPEN J Parenter Enteral Nutr. 2019;43(6):697\u2013707.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"e_1_3_1_180_1","first-page":"37","volume-title":"Essential fatty acid deficiency","author":"Mogensen K.","year":"2017","unstructured":"Mogensen K. Essential fatty acid deficiency. Pract. Gastroenterol. 2017;41(6): 37\u201344."},{"issue":"3","key":"e_1_3_1_181_1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clinbiochem.2009.08.016","article-title":"Biological variability of blood omega-3 biomarkers","volume":"43","author":"Harris WS","year":"2010","unstructured":"Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin Biochem. 2010; 2010\/02\/01\/43(3):338\u2013340.","journal-title":"Clin Biochem"},{"key":"e_1_3_1_182_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.plefa.2018.06.006","article-title":"Intra-individual variability of long-chain fatty acids (C12\u2013C24) in plasma and red blood cells","volume":"135","author":"Yuzyuk T","year":"2018","unstructured":"Yuzyuk T, Lozier B, Schwarz EL, et\u00a0al. Intra-individual variability of long-chain fatty acids (C12\u2013C24) in plasma and red blood cells. Prostaglandins Leukot Essent Fatty Acids. 2018;135:30\u201338.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"10","key":"e_1_3_1_183_1","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0022-2275(20)37132-7","article-title":"Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study","volume":"38","author":"Katan MB","year":"1997","unstructured":"Katan MB, Deslypere JP, van Birgelen AP, et\u00a0al. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J Lipid Res. 1997;38(10):2012\u20132022.","journal-title":"J Lipid Res"},{"key":"e_1_3_1_184_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.clinbiochem.2021.07.013","article-title":"Establishing age-stratified red blood cell fatty acid reference ranges using model-based clustering and iterative application of the harris-boyd method","volume":"97","author":"Balogun KA","year":"2021","unstructured":"Balogun KA, Zuromski LM, Kim R, et\u00a0al. Establishing age-stratified red blood cell fatty acid reference ranges using model-based clustering and iterative application of the harris-boyd method. Clin Biochem. 2021; 97:25\u201333.","journal-title":"Clin Biochem"},{"issue":"1","key":"e_1_3_1_185_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/mgme.2001.3170","article-title":"Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders","volume":"73","author":"Lagerstedt SA","year":"2001","unstructured":"Lagerstedt SA, Hinrichs DR, Batt SM, et\u00a0al. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab. 2001;73(1):38\u201345.","journal-title":"Mol Genet Metab"},{"key":"e_1_3_1_186_1","doi-asserted-by":"crossref","first-page":"102211","DOI":"10.1016\/j.plefa.2020.102211","article-title":"Effect of fasting status and other pre-analytical variables on quantitation of long-chain fatty acids in red blood cells","volume":"163","author":"Lozier BK","year":"2020","unstructured":"Lozier BK, Kim RN, Zuromski LM, et\u00a0al. Effect of fasting status and other pre-analytical variables on quantitation of long-chain fatty acids in red blood cells. Prostaglandins Leukot Essent Fatty Acids. 2020;163:102211.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"e_1_3_1_187_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinms.2016.12.001","article-title":"Quantitation of total fatty acids in plasma and serum by GC-NCI-MS","volume":"2","author":"Kish-Trier E","year":"2016","unstructured":"Kish-Trier E, Schwarz EL, Pasquali M, et\u00a0al. Quantitation of total fatty acids in plasma and serum by GC-NCI-MS. Clin Mass Spectrom. 2016;2:11\u201317.","journal-title":"Clin Mass Spectrom"},{"issue":"3","key":"e_1_3_1_188_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jn\/70.3.405","article-title":"The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement","volume":"70","author":"Holman RT.","year":"1960","unstructured":"Holman RT. The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr. 1960;70(3):405\u2013410.","journal-title":"J Nutr"},{"issue":"1","key":"e_1_3_1_189_1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0163-7827(91)90006-Q","article-title":"Essential fatty acids in growth and development","volume":"30","author":"Innis SM.","year":"1991","unstructured":"Innis SM. Essential fatty acids in growth and development. Prog Lipid Res. 1991;30(1):39\u2013103.","journal-title":"Prog Lipid Res"},{"issue":"12","key":"e_1_3_1_190_1","first-page":"2134","article-title":"Clinical assessment of hyperlipidemic pancreatitis","volume":"90","author":"Fortson MR","year":"1995","unstructured":"Fortson MR, Freedman SN, Webster PD. Clinical assessment of hyperlipidemic pancreatitis. Am J Gastroenterol. 1995 ;90(12):2134\u20132139.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"e_1_3_1_191_1","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/ajg.2013.218","article-title":"American college of gastroenterology guideline: management of acute pancreatitis","volume":"108","author":"Tenner S","year":"2013","unstructured":"Tenner S, Baillie J, DeWitt J, , et\u00a0al. American college of gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol. 2013;108(9):1400\u20131415; 1416. 1416.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"e_1_3_1_192_1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pan.2020.06.005","article-title":"Hypertriglyceridemia and acute pancreatitis","volume":"20","author":"Yang AL","year":"2020","unstructured":"Yang AL, McNabb-Baltar J. Hypertriglyceridemia and acute pancreatitis. Pancreatology. 2020;20(5):795\u2013800.","journal-title":"Pancreatology"},{"issue":"3","key":"e_1_3_1_193_1","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF02803766","article-title":"Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats","volume":"20","author":"Kimura W","year":"1996","unstructured":"Kimura W, Mossner J. Role of hypertriglyceridemia in the pathogenesis of experimental acute pancreatitis in rats. Int J Pancreatol. 1996;20(3):177\u2013184.","journal-title":"Int J Pancreatol"},{"issue":"5","key":"e_1_3_1_194_1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacl.2012.08.007","article-title":"Clinical and economic benefits observed when follow-up triglyceride levels are less than 500\u2009mg\/dL in patients with severe hypertriglyceridemia","volume":"6","author":"Christian JB","year":"2012","unstructured":"Christian JB, Arondekar B, Buysman EK, et\u00a0al. Clinical and economic benefits observed when follow-up triglyceride levels are less than 500\u2009mg\/dL in patients with severe hypertriglyceridemia. J Clin Lipidol. 2012; 6(5):450\u2013461.","journal-title":"J Clin Lipidol"}],"container-title":["Critical Reviews in Clinical Laboratory Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10408363.2023.2179968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T11:38:10Z","timestamp":1696419490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10408363.2023.2179968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,6]]},"references-count":193,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,7,4]]}},"alternative-id":["10.1080\/10408363.2023.2179968"],"URL":"https:\/\/doi.org\/10.1080\/10408363.2023.2179968","relation":{},"ISSN":["1040-8363","1549-781X"],"issn-type":[{"value":"1040-8363","type":"print"},{"value":"1549-781X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilab20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilab20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}